25 XP   0   0   10

Camurus AB
Buy, Hold or Sell?

Let's analyse Camurus together

PenkeI guess you are interested in Camurus AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Camurus AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Camurus AB

I send you an email if I find something interesting about Camurus AB.

Quick analysis of Camurus (30 sec.)










What can you expect buying and holding a share of Camurus? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr25.91
Expected worth in 1 year
kr34.56
How sure are you?
44.7%

+ What do you gain per year?

Total Gains per Share
kr8.65
Return On Investment
1.8%

For what price can you sell your share?

Current Price per Share
kr483.20
Expected price per share
kr317.80 - kr532.50
How sure are you?
50%

1. Valuation of Camurus (5 min.)




Live pricePrice per Share (EOD)

kr483.20

Intrinsic Value Per Share

kr106.23 - kr126.61

Total Value Per Share

kr132.14 - kr152.52

2. Growth of Camurus (5 min.)




Is Camurus growing?

Current yearPrevious yearGrowGrow %
How rich?$137.2m$85m$39.5m31.7%

How much money is Camurus making?

Current yearPrevious yearGrowGrow %
Making money$9.9m$1.2m$8.6m87.1%
Net Profit Margin21.0%5.7%--

How much money comes from the company's main activities?

3. Financial Health of Camurus (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#324 / 1009

Most Revenue
#172 / 1009

Most Profit
#96 / 1009

Most Efficient
#75 / 1009

What can you expect buying and holding a share of Camurus? (5 min.)

Welcome investor! Camurus's management wants to use your money to grow the business. In return you get a share of Camurus.

What can you expect buying and holding a share of Camurus?

First you should know what it really means to hold a share of Camurus. And how you can make/lose money.

Speculation

The Price per Share of Camurus is kr483.20. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Camurus.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Camurus, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr25.91. Based on the TTM, the Book Value Change Per Share is kr2.16 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.63 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Camurus.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.020.0%0.170.0%0.020.0%0.000.0%-0.030.0%
Usd Book Value Change Per Share0.010.0%0.200.0%0.060.0%0.100.0%0.060.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.0%0.200.0%0.060.0%0.100.0%0.060.0%
Usd Price Per Share49.44-30.94-20.07-17.81-12.65-
Price to Earnings Ratio-509.69--97.71--623.38--199.76--120.67-
Price-to-Total Gains Ratio6,615.77-1,755.92-809.09-480.00-226.92-
Price to Book Ratio20.76-14.08-13.50-12.33-11.15-
Price-to-Total Gains Ratio6,615.77-1,755.92-809.09-480.00-226.92-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share44.40608
Number of shares22
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.200.10
Usd Total Gains Per Share0.200.10
Gains per Quarter (22 shares)4.372.18
Gains per Year (22 shares)17.488.71
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1017709-1
2035240178
30524102617
40705803526
50877504435
601059205244
7012210906153
8014012607062
9015714307871
10017516008780

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%6.06.00.050.0%6.014.00.030.0%8.030.00.021.1%8.030.00.021.1%
Book Value Change Per Share4.00.00.0100.0%10.02.00.083.3%14.06.00.070.0%17.018.03.044.7%17.018.03.044.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.038.00.0%0.00.038.00.0%
Total Gains per Share4.00.00.0100.0%10.02.00.083.3%14.06.00.070.0%17.018.03.044.7%17.018.03.044.7%

Fundamentals of Camurus

About Camurus AB

Camurus AB (publ), a biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally. The company offers Buvidal, a buprenorphine injection for the treatment of opioid dependence and chronic pain and Brixadi to treat opioid use disorder. Its products pipeline also includes CAM2038 for the treatment of chronic pain; CAM2029, which is in phase III clinical trials for the treatment of acromegaly and neuroendocrine tumors, as well as in phase II clinical trial to treat polycystic liver diseases; and CAM2043 that is in phase I clinical trial for the treatment of pulmonary arterial hypertension, as well as in Phase II clinical trial to treat Raynaud's phenomenon. In addition, the company is developing CAM2032, which is in phase II clinical trials for the treatment of prostate cancer; CAM4072 that is in phase III clinical trials for the treatment of genetic obesity disorders; CAM4071, which is in phase I clinical trials for the treatment of endocrine disorder; and CAM2047 that is in phase 1 clinical trial for the treatment of chemotherapy-induced nausea and vomiting. It has strategic partnerships with Braeburn Pharmaceuticals to develop CAM2038 for the treatment of opioid use disorder; and Rhythm Pharmaceuticals Inc. to develop CAM4072 for the treatment of a range of rare genetic disorders of obesity, as well as licensing agreement with Solasia Pharma. Camurus AB (publ) was founded in 1991 and is headquartered in Lund, Sweden. The company operates as a subsidiary of Sandberg Development AB.

Fundamental data was last updated by Penke on 2024-04-20 04:09:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Camurus AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Camurus earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Camurus to the Biotechnology industry mean.
  • A Net Profit Margin of -4.1% means that kr-0.04 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Camurus AB:

  • The MRQ is -4.1%. The company is making a loss. -1
  • The TTM is 21.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ-4.1%TTM21.0%-25.0%
TTM21.0%YOY5.7%+15.3%
TTM21.0%5Y-82.6%+103.6%
5Y-82.6%10Y-181.5%+98.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.1%-200.1%+196.0%
TTM21.0%-216.8%+237.8%
YOY5.7%-288.3%+294.0%
5Y-82.6%-449.1%+366.5%
10Y-181.5%-605.5%+424.0%
1.1.2. Return on Assets

Shows how efficient Camurus is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Camurus to the Biotechnology industry mean.
  • -0.8% Return on Assets means that Camurus generated kr-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Camurus AB:

  • The MRQ is -0.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 6.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ-0.8%TTM6.3%-7.1%
TTM6.3%YOY1.1%+5.2%
TTM6.3%5Y-2.1%+8.4%
5Y-2.1%10Y-4.6%+2.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.8%-13.3%+12.5%
TTM6.3%-12.8%+19.1%
YOY1.1%-11.7%+12.8%
5Y-2.1%-13.9%+11.8%
10Y-4.6%-15.7%+11.1%
1.1.3. Return on Equity

Shows how efficient Camurus is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Camurus to the Biotechnology industry mean.
  • -1.0% Return on Equity means Camurus generated kr-0.01 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Camurus AB:

  • The MRQ is -1.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 8.0%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ-1.0%TTM8.0%-9.1%
TTM8.0%YOY1.4%+6.6%
TTM8.0%5Y-2.7%+10.8%
5Y-2.7%10Y-6.2%+3.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.0%-16.9%+15.9%
TTM8.0%-16.1%+24.1%
YOY1.4%-15.1%+16.5%
5Y-2.7%-19.3%+16.6%
10Y-6.2%-20.2%+14.0%

1.2. Operating Efficiency of Camurus AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Camurus is operating .

  • Measures how much profit Camurus makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Camurus to the Biotechnology industry mean.
  • An Operating Margin of -4.5% means the company generated kr-0.04  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Camurus AB:

  • The MRQ is -4.5%. The company is operating very inefficient. -2
  • The TTM is 26.5%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ-4.5%TTM26.5%-31.0%
TTM26.5%YOY7.4%+19.2%
TTM26.5%5Y-102.5%+129.1%
5Y-102.5%10Y-225.5%+122.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.5%-296.2%+291.7%
TTM26.5%-232.5%+259.0%
YOY7.4%-298.2%+305.6%
5Y-102.5%-492.1%+389.6%
10Y-225.5%-632.4%+406.9%
1.2.2. Operating Ratio

Measures how efficient Camurus is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.04 means that the operating costs are kr1.04 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Camurus AB:

  • The MRQ is 1.045. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.739. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ1.045TTM0.739+0.306
TTM0.739YOY0.927-0.189
TTM0.7395Y2.028-1.289
5Y2.02810Y3.252-1.224
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0453.231-2.186
TTM0.7393.310-2.571
YOY0.9273.890-2.963
5Y2.0285.739-3.711
10Y3.2527.876-4.624

1.3. Liquidity of Camurus AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Camurus is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.41 means the company has kr4.41 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Camurus AB:

  • The MRQ is 4.406. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.323. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.406TTM4.323+0.083
TTM4.323YOY3.307+1.016
TTM4.3235Y3.475+0.848
5Y3.47510Y3.871-0.396
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4063.890+0.516
TTM4.3234.173+0.150
YOY3.3075.344-2.037
5Y3.4756.126-2.651
10Y3.8716.448-2.577
1.3.2. Quick Ratio

Measures if Camurus is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Camurus to the Biotechnology industry mean.
  • A Quick Ratio of 4.13 means the company can pay off kr4.13 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Camurus AB:

  • The MRQ is 4.132. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.001. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.132TTM4.001+0.131
TTM4.001YOY2.662+1.339
TTM4.0015Y2.978+1.023
5Y2.97810Y3.548-0.570
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1323.514+0.618
TTM4.0013.998+0.003
YOY2.6625.380-2.718
5Y2.9786.105-3.127
10Y3.5486.404-2.856

1.4. Solvency of Camurus AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Camurus assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Camurus to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.22 means that Camurus assets are financed with 21.7% credit (debt) and the remaining percentage (100% - 21.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Camurus AB:

  • The MRQ is 0.217. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.211. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.217TTM0.211+0.006
TTM0.211YOY0.222-0.011
TTM0.2115Y0.213-0.002
5Y0.21310Y0.214-0.001
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2170.339-0.122
TTM0.2110.336-0.125
YOY0.2220.271-0.049
5Y0.2130.366-0.153
10Y0.2140.389-0.175
1.4.2. Debt to Equity Ratio

Measures if Camurus is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Camurus to the Biotechnology industry mean.
  • A Debt to Equity ratio of 27.8% means that company has kr0.28 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Camurus AB:

  • The MRQ is 0.278. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.268. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.278TTM0.268+0.010
TTM0.268YOY0.286-0.018
TTM0.2685Y0.272-0.004
5Y0.27210Y0.295-0.024
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2780.388-0.110
TTM0.2680.402-0.134
YOY0.2860.335-0.049
5Y0.2720.426-0.154
10Y0.2950.461-0.166

2. Market Valuation of Camurus AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Camurus generates.

  • Above 15 is considered overpriced but always compare Camurus to the Biotechnology industry mean.
  • A PE ratio of -509.69 means the investor is paying kr-509.69 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Camurus AB:

  • The EOD is -457.775. Based on the earnings, the company is expensive. -2
  • The MRQ is -509.692. Based on the earnings, the company is expensive. -2
  • The TTM is -97.707. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-457.775MRQ-509.692+51.917
MRQ-509.692TTM-97.707-411.985
TTM-97.707YOY-623.379+525.672
TTM-97.7075Y-199.757+102.050
5Y-199.75710Y-120.672-79.085
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-457.775-2.264-455.511
MRQ-509.692-2.629-507.063
TTM-97.707-2.680-95.027
YOY-623.379-4.145-619.234
5Y-199.757-6.257-193.500
10Y-120.672-6.254-114.418
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Camurus AB:

  • The EOD is 251.979. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 280.557. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 123.800. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD251.979MRQ280.557-28.577
MRQ280.557TTM123.800+156.756
TTM123.800YOY42.867+80.934
TTM123.8005Y-13.199+136.999
5Y-13.19910Y-19.200+6.001
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD251.979-2.973+254.952
MRQ280.557-3.333+283.890
TTM123.800-3.553+127.353
YOY42.867-5.605+48.472
5Y-13.199-8.376-4.823
10Y-19.200-8.865-10.335
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Camurus is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 20.76 means the investor is paying kr20.76 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Camurus AB:

  • The EOD is 18.650. Based on the equity, the company is expensive. -2
  • The MRQ is 20.765. Based on the equity, the company is expensive. -2
  • The TTM is 14.082. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD18.650MRQ20.765-2.115
MRQ20.765TTM14.082+6.683
TTM14.082YOY13.497+0.585
TTM14.0825Y12.335+1.747
5Y12.33510Y11.154+1.181
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD18.6501.896+16.754
MRQ20.7652.115+18.650
TTM14.0822.093+11.989
YOY13.4972.884+10.613
5Y12.3353.542+8.793
10Y11.1543.916+7.238
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Camurus AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0812.162-96%0.632-87%1.077-92%0.682-88%
Book Value Per Share--25.91023.534+10%16.066+61%15.041+72%10.955+137%
Current Ratio--4.4064.323+2%3.307+33%3.475+27%3.871+14%
Debt To Asset Ratio--0.2170.211+3%0.222-2%0.213+2%0.214+1%
Debt To Equity Ratio--0.2780.268+4%0.286-3%0.272+2%0.295-6%
Dividend Per Share----0%-0%-0%-0%
Eps---0.2641.872-114%0.241-210%-0.053-80%-0.298+13%
Free Cash Flow Per Share--0.4792.589-81%0.431+11%-0.108+123%-0.324+168%
Free Cash Flow To Equity Per Share--0.6752.714-75%0.620+9%0.910-26%0.710-5%
Gross Profit Margin--8.3552.166+286%15.871-47%5.393+55%3.468+141%
Intrinsic Value_10Y_max--126.610--------
Intrinsic Value_10Y_min--106.234--------
Intrinsic Value_1Y_max--4.551--------
Intrinsic Value_1Y_min--4.466--------
Intrinsic Value_3Y_max--19.876--------
Intrinsic Value_3Y_min--18.850--------
Intrinsic Value_5Y_max--42.675--------
Intrinsic Value_5Y_min--39.076--------
Market Cap27843723520.000-11%31001496800.00019401866120.000+60%12584669669.600+146%11169693709.920+178%7930868252.929+291%
Net Profit Margin---0.0410.210-119%0.057-172%-0.826+1935%-1.815+4371%
Operating Margin---0.0450.265-117%0.074-161%-1.025+2195%-2.255+4947%
Operating Ratio--1.0450.739+41%0.927+13%2.028-48%3.252-68%
Pb Ratio18.650-11%20.76514.082+47%13.497+54%12.335+68%11.154+86%
Pe Ratio-457.775+10%-509.692-97.707-81%-623.379+22%-199.757-61%-120.672-76%
Price Per Share483.200-11%538.000336.700+60%218.350+146%193.830+178%137.628+291%
Price To Free Cash Flow Ratio251.979-11%280.557123.800+127%42.867+554%-13.199+105%-19.200+107%
Price To Total Gains Ratio5941.896-11%6615.7701755.920+277%809.089+718%480.004+1278%226.925+2815%
Quick Ratio--4.1324.001+3%2.662+55%2.978+39%3.548+16%
Return On Assets---0.0080.063-113%0.011-171%-0.021+166%-0.046+480%
Return On Equity---0.0100.080-113%0.014-171%-0.027+167%-0.062+514%
Total Gains Per Share--0.0812.162-96%0.632-87%1.077-92%0.682-88%
Usd Book Value--137206791.900124629266.000+10%85094805.000+61%79651931.005+72%58013093.884+137%
Usd Book Value Change Per Share--0.0070.199-96%0.058-87%0.099-92%0.063-88%
Usd Book Value Per Share--2.3812.163+10%1.476+61%1.382+72%1.007+137%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.0240.172-114%0.022-210%-0.005-80%-0.027+13%
Usd Free Cash Flow--2538737.50013710354.225-81%2281279.650+11%-573984.425+123%-1715436.839+168%
Usd Free Cash Flow Per Share--0.0440.238-81%0.040+11%-0.010+123%-0.030+168%
Usd Free Cash Flow To Equity Per Share--0.0620.249-75%0.057+9%0.084-26%0.065-5%
Usd Market Cap2558838191.488-11%2849037555.9201783031496.428+60%1156531142.636+146%1026494851.942+178%728846792.444+291%
Usd Price Per Share44.406-11%49.44230.943+60%20.066+146%17.813+178%12.648+291%
Usd Profit---1397431.4009912379.950-114%1276330.175-209%-278369.695-80%-1579347.450+13%
Usd Revenue--34422615.40039444628.750-13%21971911.500+57%17072088.390+102%10317941.905+234%
Usd Total Gains Per Share--0.0070.199-96%0.058-87%0.099-92%0.063-88%
 EOD+3 -5MRQTTM+11 -23YOY+17 -175Y+20 -1410Y+24 -10

3.2. Fundamental Score

Let's check the fundamental score of Camurus AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-457.775
Price to Book Ratio (EOD)Between0-118.650
Net Profit Margin (MRQ)Greater than0-0.041
Operating Margin (MRQ)Greater than0-0.045
Quick Ratio (MRQ)Greater than14.132
Current Ratio (MRQ)Greater than14.406
Debt to Asset Ratio (MRQ)Less than10.217
Debt to Equity Ratio (MRQ)Less than10.278
Return on Equity (MRQ)Greater than0.15-0.010
Return on Assets (MRQ)Greater than0.05-0.008
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Camurus AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.308
Ma 20Greater thanMa 50501.395
Ma 50Greater thanMa 100490.368
Ma 100Greater thanMa 200505.194
OpenGreater thanClose475.000
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income before Tax  20,49356,38076,873303,736380,609-270,774109,835-127,848-18,013
Net Income  13,06745,76258,829242,594301,423-215,02786,396-101,602-15,206
EBIT  18,87955,45674,335301,725376,060-265,899110,161-126,895-16,734
EBITDA  24,76955,67480,443303,874384,317-270,678113,639-126,482-12,843
Operating Income  18,87955,45674,335301,725376,060-272,013104,047-120,781-16,734
Tax Provision  7,42610,61818,04461,14279,186-55,74723,439-26,246-2,807
Income Tax Expense  7,42610,61818,04461,14279,186-55,74723,439-26,246-2,807
Total Other Income Expense Net 1,6149242,5382,0114,5491,2395,788-7,067-1,279
Net Income from Continuing Operations  13,06745,76258,829242,594301,423-215,02786,396-101,602-15,206



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets1,907,820
Total Liabilities414,819
Total Stockholder Equity1,493,001
 As reported
Total Liabilities 414,819
Total Stockholder Equity+ 1,493,001
Total Assets = 1,907,820

Assets

Total Assets1,907,820
Total Current Assets1,624,069
Long-term Assets283,751
Total Current Assets
Cash And Cash Equivalents 1,189,840
Net Receivables 333,274
Inventory 100,955
Total Current Assets  (as reported)1,624,069
Total Current Assets  (calculated)1,624,069
+/-0
Long-term Assets
Property Plant Equipment 39,682
Intangible Assets 22,749
Long-term Assets Other 22,749
Long-term Assets  (as reported)283,751
Long-term Assets  (calculated)85,180
+/- 198,571

Liabilities & Shareholders' Equity

Total Current Liabilities368,594
Long-term Liabilities46,225
Total Stockholder Equity1,493,001
Total Current Liabilities
Short-term Debt 10,894
Accounts payable 99,278
Other Current Liabilities 247,139
Total Current Liabilities  (as reported)368,594
Total Current Liabilities  (calculated)357,311
+/- 11,283
Long-term Liabilities
Capital Lease Obligations 24,507
Long-term Liabilities  (as reported)46,225
Long-term Liabilities  (calculated)24,507
+/- 21,718
Total Stockholder Equity
Common Stock1,391
Retained Earnings -550,893
Accumulated Other Comprehensive Income 2,478
Other Stockholders Equity 2,040,025
Total Stockholder Equity (as reported)1,493,001
Total Stockholder Equity (calculated)1,493,001
+/-0
Other
Capital Stock1,391
Cash and Short Term Investments 1,189,840
Common Stock Shares Outstanding 55,555
Current Deferred Revenue11,283
Liabilities and Stockholders Equity 1,907,820
Net Debt -1,165,333
Net Invested Capital 1,493,001
Net Working Capital 1,255,475
Property Plant and Equipment Gross 63,421
Short Long Term Debt Total 24,507



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302013-12-312012-12-31
> Total Assets 
57,405
111,656
0
207,668
0
0
210,220
816,349
676,186
660,261
648,972
639,776
597,593
570,403
520,418
475,934
435,872
490,133
441,458
364,724
703,406
625,166
565,439
772,046
730,351
723,379
989,624
1,044,098
1,029,567
1,045,732
1,046,007
1,081,897
1,092,248
1,132,705
1,233,555
1,305,488
1,349,953
1,773,556
1,841,665
1,907,820
1,907,8201,841,6651,773,5561,349,9531,305,4881,233,5551,132,7051,092,2481,081,8971,046,0071,045,7321,029,5671,044,098989,624723,379730,351772,046565,439625,166703,406364,724441,458490,133435,872475,934520,418570,403597,593639,776648,972660,261676,186816,349210,22000207,6680111,65657,405
   > Total Current Assets 
0
0
0
177,592
0
0
154,374
749,574
604,640
583,661
568,022
549,592
495,884
456,493
392,419
334,382
284,395
321,837
260,205
166,895
447,776
340,601
265,037
439,690
383,266
373,011
633,567
668,486
650,399
654,742
650,911
679,302
694,558
741,800
839,486
915,345
975,436
1,468,546
1,564,555
1,624,069
1,624,0691,564,5551,468,546975,436915,345839,486741,800694,558679,302650,911654,742650,399668,486633,567373,011383,266439,690265,037340,601447,776166,895260,205321,837284,395334,382392,419456,493495,884549,592568,022583,661604,640749,574154,37400177,592000
       Cash And Cash Equivalents 
0
0
0
56
0
0
112,347
716,096
571,916
548,983
518,248
508,594
463,804
413,360
369,748
314,524
266,633
199,093
216,347
134,377
406,622
283,066
192,331
358,744
291,301
222,004
475,730
461,793
427,822
421,894
426,477
411,575
399,850
428,132
519,541
565,539
585,830
654,090
1,153,854
1,189,840
1,189,8401,153,854654,090585,830565,539519,541428,132399,850411,575426,477421,894427,822461,793475,730222,004291,301358,744192,331283,066406,622134,377216,347199,093266,633314,524369,748413,360463,804508,594518,248548,983571,916716,096112,3470056000
       Net Receivables 
43,739
81,879
0
174,729
0
0
29,941
27,096
29,566
31,530
21,077
24,144
12,148
18,240
12,606
11,564
5,973
109,943
25,396
22,689
5,452
15,061
22,553
41,349
46,800
60,272
53,631
89,607
104,897
118,319
112,308
136,000
145,000
151,000
169,000
196,863
290,157
707,816
306,606
333,274
333,274306,606707,816290,157196,863169,000151,000145,000136,000112,308118,319104,89789,60753,63160,27246,80041,34922,55315,0615,45222,68925,396109,9435,97311,56412,60618,24012,14824,14421,07731,53029,56627,09629,94100174,729081,87943,739
       Other Current Assets 
1,105
1,779
0
176,834
0
0
39,457
30,237
1
-1
45,817
28,618
23,829
29,085
19,557
16,305
15,398
6,480
36,636
-1
24,967
33,149
37,415
47,854
54,912
68,754
63,297
95,344
113,339
126,968
119,841
24,525
36,026
45,246
33,552
0
44,082
419,066
0
18,145
18,1450419,06644,082033,55245,24636,02624,525119,841126,968113,33995,34463,29768,75454,91247,85437,41533,14924,967-136,6366,48015,39816,30519,55729,08523,82928,61845,817-1130,23739,45700176,83401,7791,105
   > Long-term Assets 
0
0
0
30,076
0
0
55,846
66,775
71,546
76,600
80,950
90,185
101,710
113,910
127,999
141,552
151,477
168,296
181,253
197,829
255,630
284,565
300,402
332,356
347,085
350,368
356,057
375,612
379,168
390,990
395,096
402,595
397,690
390,905
394,069
390,143
374,517
305,010
277,110
283,751
283,751277,110305,010374,517390,143394,069390,905397,690402,595395,096390,990379,168375,612356,057350,368347,085332,356300,402284,565255,630197,829181,253168,296151,477141,552127,999113,910101,71090,18580,95076,60071,54666,77555,8460030,076000
       Property Plant Equipment 
2,461
3,176
0
7,119
0
0
6,566
6,634
6,450
6,229
7,371
9,759
10,463
10,259
9,798
9,902
10,053
11,256
11,226
10,899
39,371
39,029
37,333
38,385
36,693
35,194
32,847
33,898
32,197
31,101
34,088
34,728
33,764
31,839
34,334
34,880
33,025
39,704
38,930
39,682
39,68238,93039,70433,02534,88034,33431,83933,76434,72834,08831,10132,19733,89832,84735,19436,69338,38537,33339,02939,37110,89911,22611,25610,0539,9029,79810,25910,4639,7597,3716,2296,4506,6346,566007,11903,1762,461
       Intangible Assets 
0
0
0
22,551
0
0
21,344
20,823
20,303
19,782
19,262
18,741
18,219
17,697
17,175
16,653
16,128
15,609
15,090
15,975
19,975
26,095
27,305
37,335
37,221
36,798
36,278
36,597
35,638
34,980
33,859
33,713
32,742
24,489
24,043
23,597
24,088
23,641
23,195
22,749
22,74923,19523,64124,08823,59724,04324,48932,74233,71333,85934,98035,63836,59736,27836,79837,22137,33527,30526,09519,97515,97515,09015,60916,12816,65317,17517,69718,21918,74119,26219,78220,30320,82321,3440022,551000
       Long-term Assets Other 
0
0
0
406
0
0
0
1
-1
0
0
0
1
0
0
0
0
0
0
0
255,630
284,565
300,402
-1
347,085
0
0
1
0
324,909
327,149
334,154
331,184
334,577
6,983
6,999
7,001
7,587
1,334
22,749
22,7491,3347,5877,0016,9996,983334,577331,184334,154327,149324,9090100347,085-1300,402284,565255,63000000001000-11000406000
> Total Liabilities 
17,195
61,609
0
84,211
0
0
107,155
175,792
55,045
56,424
57,462
75,359
73,424
81,544
83,571
90,934
86,993
107,142
101,900
112,400
142,196
144,686
147,476
140,412
159,829
173,765
165,965
196,657
202,025
226,054
218,539
232,989
238,900
245,370
265,109
310,817
288,587
391,678
353,350
414,819
414,819353,350391,678288,587310,817265,109245,370238,900232,989218,539226,054202,025196,657165,965173,765159,829140,412147,476144,686142,196112,400101,900107,14286,99390,93483,57181,54473,42475,35957,46256,42455,045175,792107,1550084,211061,60917,195
   > Total Current Liabilities 
15,434
57,032
0
75,674
0
0
107,155
175,791
55,045
56,425
57,462
75,358
73,424
81,543
83,571
90,934
86,993
107,142
101,900
112,400
117,740
121,051
124,662
117,474
137,992
153,060
147,342
176,270
182,906
207,892
197,705
213,045
219,682
225,604
237,947
281,642
263,939
354,950
309,620
368,594
368,594309,620354,950263,939281,642237,947225,604219,682213,045197,705207,892182,906176,270147,342153,060137,992117,474124,662121,051117,740112,400101,900107,14286,99390,93483,57181,54373,42475,35857,46256,42555,045175,791107,1550075,674057,03215,434
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,399
3,399
3,399
4,394
4,419
4,444
5,125
5,094
5,097
5,101
6,556
6,731
6,722
6,700
7,772
9,574
9,238
10,347
10,456
10,894
10,89410,45610,3479,2389,5747,7726,7006,7226,7316,5565,1015,0975,0945,1254,4444,4194,3943,3993,3993,39900000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,399
3,399
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000003,3993,39900000000000000000000
       Accounts payable 
6,288
7,769
0
9,938
0
0
14,177
31,832
7,566
7,571
7,832
17,560
13,053
17,133
17,782
15,086
12,579
29,186
19,302
35,781
16,837
17,860
17,033
17,387
20,968
31,366
28,148
20,712
49,152
31,603
31,598
52,857
28,993
40,106
46,467
85,548
49,311
80,806
74,565
99,278
99,27874,56580,80649,31185,54846,46740,10628,99352,85731,59831,60349,15220,71228,14831,36620,96817,38717,03317,86016,83735,78119,30229,18612,57915,08617,78217,13313,05317,5607,8327,5717,56631,83214,177009,93807,7696,288
       Other Current Liabilities 
9,146
49,263
0
65,736
0
0
92,978
143,959
47,479
48,854
49,630
57,798
60,371
64,410
65,789
75,848
74,414
77,956
82,598
76,619
11,368
8,570
9,260
5,806
14,899
8,831
10,353
11,218
21,092
17,118
16,252
20,960
183,967
178,798
183,708
186,520
205,390
39,739
35,208
247,139
247,13935,20839,739205,390186,520183,708178,798183,96720,96016,25217,11821,09211,21810,3538,83114,8995,8069,2608,57011,36876,61982,59877,95674,41475,84865,78964,41060,37157,79849,63048,85447,479143,95992,9780065,736049,2639,146
   > Long-term Liabilities 
0
0
0
8,537
0
0
14,177
1
7,566
-1
7,832
1
13,052
1
17,782
15,086
12,579
29,186
19,302
35,781
24,456
23,635
22,814
22,938
21,837
20,705
18,623
20,387
19,119
18,162
20,834
19,944
19,218
19,766
27,162
29,175
24,648
36,728
43,730
46,225
46,22543,73036,72824,64829,17527,16219,76619,21819,94420,83418,16219,11920,38718,62320,70521,83722,93822,81423,63524,45635,78119,30229,18612,57915,08617,782113,05217,832-17,566114,177008,537000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,623
20,387
19,119
17,836
19,892
18,925
17,266
15,600
17,360
16,643
14,765
16,427
14,836
0
014,83616,42714,76516,64317,36015,60017,26618,92519,89217,83619,11920,38718,62300000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
1
0
0
0
0
-1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
326
942
1,019
1,952
4,166
9,802
12,532
0
0
0
0
000012,5329,8024,1661,9521,0199423260000000000000001-1000010000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
18,741
18,219
17,697
17,175
16,653
16,128
15,609
15,090
15,975
19,975
26,095
27,305
37,335
37,221
36,798
36,278
36,597
35,638
34,980
33,859
33,713
32,742
24,489
24,043
23,597
0
0
0
0
000023,59724,04324,48932,74233,71333,85934,98035,63836,59736,27836,79837,22137,33527,30526,09519,97515,97515,09015,60916,12816,65317,17517,69718,21918,74100000000000
> Total Stockholder Equity
40,210
50,047
0
123,457
123,457
0
103,065
640,557
621,141
603,837
591,510
564,417
524,169
488,859
436,847
385,000
348,879
382,991
339,558
252,324
561,210
480,480
417,963
631,634
570,522
549,614
823,659
847,441
827,542
819,678
827,468
848,908
853,348
887,335
968,446
994,671
1,061,366
1,381,878
1,488,315
1,493,001
1,493,0011,488,3151,381,8781,061,366994,671968,446887,335853,348848,908827,468819,678827,542847,441823,659549,614570,522631,634417,963480,480561,210252,324339,558382,991348,879385,000436,847488,859524,169564,417591,510603,837621,141640,557103,0650123,457123,457050,04740,210
   Common Stock
583
583
0
630
0
0
630
932
932
932
932
932
932
932
932
932
932
960
960
960
1,199
1,199
1,199
1,291
1,291
1,291
1,341
1,356
1,356
1,364
1,365
1,371
1,371
1,375
1,385
1,386
1,386
1,387
1,389
1,391
1,3911,3891,3871,3861,3861,3851,3751,3711,3711,3651,3641,3561,3561,3411,2911,2911,2911,1991,1991,199960960960932932932932932932932932932932630006300583583
   Retained Earnings 
6,010
15,847
0
64,193
0
0
43,801
13,444
-5,972
-26,523
-39,738
-67,549
-107,797
-153,597
-205,925
-258,107
-294,228
-359,651
-405,557
-492,776
-560,172
-647,811
-710,383
-782,344
-843,456
-864,336
-884,427
-950,999
-971,561
-1,020,557
-1,026,629
-1,039,858
-1,039,712
-1,030,008
-993,949
-980,448
-921,868
-616,466
-532,446
-550,893
-550,893-532,446-616,466-921,868-980,448-993,949-1,030,008-1,039,712-1,039,858-1,026,629-1,020,557-971,561-950,999-884,427-864,336-843,456-782,344-710,383-647,811-560,172-492,776-405,557-359,651-294,228-258,107-205,925-153,597-107,797-67,549-39,738-26,523-5,97213,44443,8010064,193015,8476,010
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,412,687
1,412,687
1,412,659
1,706,745
1,797,084
1,797,747
1,838,871
1,852,732
1,887,395
1,891,689
1,915,968
1,961,010
1,973,733
1,981,848
1,996,957
2,019,372
0
02,019,3721,996,9571,981,8481,973,7331,961,0101,915,9681,891,6891,887,3951,852,7321,838,8711,797,7471,797,0841,706,7451,412,6591,412,6871,412,68700000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
58,634
0
0
58,634
626,181
626,181
629,428
630,316
631,034
631,034
641,524
641,840
642,175
642,175
741,682
744,155
744,140
1,120,183
1,127,092
1,127,147
1,412,687
1,412,687
1,412,659
1,706,745
1,797,084
1,797,747
1,838,871
1,852,732
1,887,395
1,891,689
1,915,968
1,961,010
1,973,733
1,981,848
1,996,957
2,019,372
2,040,025
2,040,0252,019,3721,996,9571,981,8481,973,7331,961,0101,915,9681,891,6891,887,3951,852,7321,838,8711,797,7471,797,0841,706,7451,412,6591,412,6871,412,6871,127,1471,127,0921,120,183744,140744,155741,682642,175642,175641,840641,524631,034631,034630,316629,428626,181626,18158,6340058,634000



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,716,850
Cost of Revenue-136,335
Gross Profit1,580,5151,580,515
 
Operating Income (+$)
Gross Profit1,580,515
Operating Expense-1,048,160
Operating Income532,355532,355
 
Operating Expense (+$)
Research Development623,709
Selling General Administrative48,629
Selling And Marketing Expenses375,822
Operating Expense1,048,1601,048,160
 
Net Interest Income (+$)
Interest Income15,989
Interest Expense-1,275
Other Finance Cost-225
Net Interest Income14,489
 
Pretax Income (+$)
Operating Income532,355
Net Interest Income14,489
Other Non-Operating Income Expenses0
Income Before Tax (EBT)549,304515,406
EBIT - interestExpense = 531,080
549,304
432,717
Interest Expense1,275
Earnings Before Interest and Taxes (EBIT)532,355550,579
Earnings Before Interest and Taxes (EBITDA)546,342
 
After tax Income (+$)
Income Before Tax549,304
Tax Provision-128,095
Net Income From Continuing Ops459,715421,209
Net Income431,442
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,184,495
Total Other Income/Expenses Net16,949-14,489
 

Technical Analysis of Camurus
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Camurus. The general trend of Camurus is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Camurus's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Camurus AB.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 493.00 < 522.50 < 532.50.

The bearish price targets are: 417.40 > 343.40 > 317.80.

Tweet this
Camurus AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Camurus AB. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Camurus AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Camurus AB. The current macd is -4.74111515.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Camurus price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Camurus. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Camurus price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Camurus AB Daily Moving Average Convergence/Divergence (MACD) ChartCamurus AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Camurus AB. The current adx is 14.93.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Camurus shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Camurus AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Camurus AB. The current sar is 508.00.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Camurus AB Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Camurus AB. The current rsi is 44.31. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Camurus AB Daily Relative Strength Index (RSI) ChartCamurus AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Camurus AB. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Camurus price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Camurus AB Daily Stochastic Oscillator ChartCamurus AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Camurus AB. The current cci is -123.521682.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Camurus AB Daily Commodity Channel Index (CCI) ChartCamurus AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Camurus AB. The current cmo is -14.57293331.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Camurus AB Daily Chande Momentum Oscillator (CMO) ChartCamurus AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Camurus AB. The current willr is -68.34782609.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Camurus is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Camurus AB Daily Williams %R ChartCamurus AB Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Camurus AB.

Camurus AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Camurus AB. The current atr is 16.94.

Camurus AB Daily Average True Range (ATR) ChartCamurus AB Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Camurus AB. The current obv is 5,533,812.

Camurus AB Daily On-Balance Volume (OBV) ChartCamurus AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Camurus AB. The current mfi is 44.49.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Camurus AB Daily Money Flow Index (MFI) ChartCamurus AB Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Camurus AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-10BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Camurus AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Camurus AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.308
Ma 20Greater thanMa 50501.395
Ma 50Greater thanMa 100490.368
Ma 100Greater thanMa 200505.194
OpenGreater thanClose475.000
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Camurus with someone you think should read this too:
  • Are you bullish or bearish on Camurus? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Camurus? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Camurus AB

I send you an email if I find something interesting about Camurus AB.


Comments

How you think about this?

Leave a comment

Stay informed about Camurus AB.

Receive notifications about Camurus AB in your mailbox!